John Garofalo
 |
John Garofalo, PharmD
Associate Director Clinical Pharmacy Services
Hospital Pharmacy |
| Email |
garofalo@uic.edu |
| Phone |
312-996-7678 |
| Fax |
312-413-4146 |
| Office |
C300 UICMC MC 883 |
| US Mail |
1740 West Taylor Street, Room C-300 (MC 883),Chicago, Illinois 60612-7232 |
Research Interests
Dr. Garofalo's clinical research interests include disorders related to critical care, the gastrointestinal system and nutritional support. He is also involved with research associated with federally mandated quality initiatives.
Education |
| 1989 |
ASHP Accredited Clinical Pharmacy Residency- Chief Resident, University of Illinois Hospital |
| 1988 |
Doctor of Pharmacy, High Honors, University of Illinois at Chicago, College of Pharmacy, Chicago, IL |
| 1983 |
Pre-Pharmacy, Dean's List, Elmhurst College, Elmhurst, IL |
|
|
|
|
| 1989 to present |
Clinical Assistant Professor, Department of Pharmacy Practice |
| 2003 to present |
Associate Director, Clinical Pharmacy Services, Medical Center |
| Representative Publications |
- Co-Investigator, "Evaluation of current practice in the treatment of severe sepsis and development of practice guidelines for treatment of severe sepsis." R Yeh, J Garofalo, A Donnelly, et al. Poster Presentation. SCCM meeting. January 2005. Eli Lilly and Company. Amount $74, 880.
- Principle Investigator, "Evaluation of twice daily dosing of proton pump inhibitors in an outpatient university teaching hospital." J Garofalo, N Boyea, R Costianis, S Durley, J Chan. Poster Presentation. ASHP Midyear meeting. Atlanta, Georgia. December 2002.
- Co-Investigator, "Interpreting total, free, and adjusted phenytoin concentrations in medical intensive care patients.'' J Mucksavage, J Garofalo, L Chan. Poster Presentation. ACCP Annual meeting. Albuquerque, New Mexico. October 2002.
- Principle Investigator, "Evaluation of physician prescribing habits of proton pump inhibitors in a university hospital." J Garofalo, A Moy, J Chan. Poster Presentation. ASHP Midyear meeting. New Orleans, Louisiana. December 2001. Tap Pharmaceuticals. Amount $3915.
- Co-Investigator, "Association of histamine type II receptor antagonist with thrombocytopenia: Incidence and clinical outcome." J Chan, J Garofalo. Poster Presentation. ACCP annual meeting. Tampa, Florida. October 2001. Tap Pharmaceuticals. Amount $2940.
Click here to view Dr. Garofalo's on-line CV. 
Return to faculty list
